Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
The positive impact of GLP-1RA therapy on lipids is an important contributor to these outcomes
Maintaining a healthy sleep schedule, eating balanced meals, and staying active can help
Lankas GR, Leiting B, Roy RS, et al
&srotate=0)
US$ 24.11
US$ 27.01
US$ 20.53
